Karen T. Liby

Biochemistry, Genetics and Molecular Biology · Indiana University

Genomics, phytochemicals, and oxidative stress Protein Degradation and Inhibitors Estrogen and related hormone effects Retinoids in leukemia and cellular processes Click Chemistry and Applications

Publications

265

Citations

10,404

Est. group size

—

Recurring co-author estimate

Active years

Publishing since 1999

Publication cadence

Publications per year over the last 10 years — averaging 18.8/year recently

Recent publications

Health position paper and redox perspectives – Bench to bedside transition for pharmacological regulation of NRF2 in noncommunicable diseases
Redox Biology · 2025
Abstract 3165: Leveraging chemoinformatics and high-throughput screening for the identification of novel ubiquitin specific protease 7 (USP7) inhibitors
Cancer Research · 2025
Abstract 3096: The RXR agonist MSU-42011 and the MEK inhibitor selumetinib reduce tumor burden by decreasing pERK levels and modulating immune cell populations within the NF1 tumor microenvironment
Cancer Research · 2025
Abstract 3450: The role of NRF2-HO-1 expressing macrophages in lung cancer progression
Cancer Research · 2025
The RXR Agonist MSU-42011 Reduces Tumor Burden in a Murine Preclinical NF1-Deficient Model
Cancers · 2025
1002 A novel RXR agonist suppresses tumor formation accompanied by increased CD8+ T cells in a murine model of cutaneous T cell lymphoma (CTCL)
Journal of Investigative Dermatology · 2025
Understanding how treatment responses alter the myeloid compartment in BRAF-mutant melanoma 2604
The Journal of Immunology · 2025
Synthetic Oleanane Triterpenoids Reduce Tumor Growth and Promote an Anti-Tumor Immune Response Independent of Cancer KEAP1 Mutational Status
Antioxidants · 2025
Abstract 3130: Differential gene expression regulation by the RXR agonist V-125 in MMTV-Neu mammary tumors
Cancer Research · 2025
RXR Agonist V-125 Induces Distinct Transcriptional and Immunomodulatory Programs in Mammary Tumors of MMTV-Neu Mice Compared to Bexarotene
Biomedicines · 2025
KEAP1-Mutant Lung Cancers Weaken Anti-Tumor Immunity and Promote an M2-like Macrophage Phenotype
International Journal of Molecular Sciences · 2024
The Triterpenoid CDDO-Methyl Ester Reduces Tumor Burden, Reprograms the Immune Microenvironment, and Protects from Chemotherapy-Induced Toxicity in a Preclinical Mouse Model of Established Lung Cancer
Antioxidants · 2024
The BRD4 Inhibitor I-BET-762 Reduces HO-1 Expression in Macrophages and the Pancreas of Mice
International Journal of Molecular Sciences · 2024
Editorial: Furthering precision medicine and cancer prevention through novel insights in molecular and chemical carcinogenesis
Frontiers in Oncology · 2024
Abstract 726: The retinoid X receptor agonist MSU42011 enhances efficacy of anti-PD1 therapy in a HER2+ breast cancer model through a CD4-IL12 axis
Cancer Research · 2024

Publishes in

Cancer Research×31
Scientific Reports×7
The Journal of Immunology×5
Cancer Prevention Research×3
Cancers×3

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 9, 2026.

Claim or correct this profile